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May 12, 2009:1824–7ive coronary angiography (ICA), significant stenoses are defined
s 50% on both quantitative assessment of ICA and visual
stimation of CTCA, with the 2 techniques subsequently com-
ared. The major flaw with this approach is that a measurement of
0% on quantitative coronary angiography is the equivalent of a
isual stenosis of 70%, and therefore there is a systematic overes-
imation of stenosis severity by CTCA contributing to the large
umber of false-positive results. This high false-positive rate is
hen used to highlight the shortcomings of CTCA.
The argument for the use of a 50% stenosis cutoff for CTCA is
ue to the limited spatial resolution of CTCA as discussed in the
issen editorial (2). However, the majority of symptomatic pa-
ients show stenoses well in excess of 70%, and our own previous
ork clearly shows an increase in the positive predictive value of
TCA as compared with single-photon emission computed to-
ography when using a visual cutoff of 70% (3). Furthermore, our
wn validation data demonstrate that this is also true for compar-
son with ICA. In this setting, the associated increase in specificity
ssociated with using a 70% cutoff comes at a cost of significantly
educed sensitivity whilst delivering an identical area under the
urve.
So, although we agree with Nissen’s view (2) that there is no
roven benefit for multimodality noninvasive assessment of coro-
ary artery disease, the targeted use of a combined approach for
atients with apparent lesions of 50% to 69% on CTCA would
llow a more reliable determination of significance in these
ntermediate lesions.
Second, we absolutely share the view that the rapid proliferation
f CTCA and so called “weekend accreditation” is not an appro-
riate strategy for high-quality patient care and therefore would
rgue that both more rigorous accreditation is needed and further
esearch into the most appropriate use of the technology is
aramount.
Third, we would agree that the current research on this
echnology does not support its use beyond the exclusion of
ignificant coronary artery disease. Efforts should now focus on
nswering some of the more fundamental issues limiting the
linical use of CTCA rather than on the exploration of the latest
ew iteration of this seductive technology. We would agree that
urther real-world studies are required. These would include
ssessing the use of a visual 70% stenosis cutoff for defining
ignificant lesions, with the use of a targeted functional testing for
hose with intermediate lesions (50% to 69%). We would also
upport longer-term studies assessing outcome data in patients
valuated with this technology compared with conventional assess-
ent. However, we should not write off CTCA, because there are
ew medical tests that reliably offer a negative predictive value in
xcess of 90%, confirmed again by this study.
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eply
oronary multidetector computed tomography (MDCT) is a
elatively recent noninvasive diagnostic modality. The first 4-slice
omputed tomography (CT) scan was introduced in 1999; since
hen the technique has undergone rapid technological improve-
ents, with introduction of 64-, 128-, 256-, and 320-slice MDCT
canners that have resulted in better, high-quality coronary images.
oronary CT has an enormous appeal, not only because of the
ometimes spectacular and seductive cardiac images—this nonin-
asive diagnostic modality may potentially be able to replace
nvasive coronary angiography. This might have led to initial
ver-enthusiasm that prompted use of this new technique in many
linical situations, although the necessary evidence to support this
as lacking.
However, in the meantime, many CT studies have been
ublished, and together with 3 large-sized multicenter studies it
as been clearly shown that: 1) coronary MDCT is reliable to
ule out the presence of significant coronary stenoses in patients
ith suspected coronary artery disease; and 2) the current
tate-of-the-art CT technique cannot replace invasive coronary
ngiography (1–3). We agree with Drs. Min and Berman that
he ability of CT to exclude disease is important for patients.
ut we also know that coronary CT is not perfect. Several
ssues, including radiation exposure, calcifications, and arrhyth-
ias, are still problematic for coronary CT scanning. Ini-
ially coronary MDCT was associated with a rather high radia-
ion exposure; new protocols (prospective electrocardiogram
ECG]-triggered acquisition) or radiation exposure-reducing
echnology (ECG gated tube modulation) have now achieved
cceptable radiation exposure—as low as 2 to 3 mSv (4).
oronary calcification causing misinterpretation of the presence
nd severity of coronary stenoses remains a significant problem
hat can only be alleviated by better CT detector technology
hat significantly improves the spatial resolution. Very recently
he Gemstone scintillator technology has been introduced that,
n an ideal phantom setting, significantly improved the spatial
esolution up to 230 m. Also the problems of significant
ardiac arrhythmias (atrial fibrillation), which are still problematic
or cardiac CT, will be resolved by new CT technology that needs
nly 1 heartbeat to acquire data for coronary imaging. Another
roblem, raised by Dr. Nicol and colleagues, is overestimation of
isual assessment of the severity of CT coronary stenoses, which has
n the past also been a problem with invasive coronary angiography.
ccurate automated contour-detection algorithms developed for cor-
nary MDCT might resolve this issue. Another important issue
aised by Dr. Nicol and colleagues is the mismatch between CT
natomy imaging and functional imaging. The assumption that a
ignificant stenosis defined as 50% luminal diameter is hemody-
amically significant is not always confirmed by myocardial perfusion
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May 12, 2009:1824–7maging or invasive coronary stenosis pressure measurements (frac-
ional flow reserve), and in particular a significant mismatch between
natomical severity of a stenosis and functional severity of a stenosis
ften occurs in intermediate lesions (5,6). However, increasing the
everity of a stenosis to a cutoff level of 70% will result in a better
greement with myocardial perfusion imaging as suggested by Dr.
icol and colleagues, but the price to be paid is lower sensitivity and
onsequent decrease in negative predictive value, which is considered
of the major strengths of coronary CT imaging. We agree with Dr.
icol and colleagues that more studies are required to define the most
cceptable cutoff level of the severity of a stenosis (50% vs. 70%) either
etermined by visual or automated contour detection algorithms.
Importantly, only scant information is available about the
ole of noninvasive coronary anatomy information as compared
ith functional information obtained by exercise ECG stress
esting, stress echocardiography, or single-photon emission
omputed tomography. It is always difficult for a new diagnostic
odality to establish its role among already available diagnostic
odalities, and it will take time to provide scientific evidence to
emonstrate the diagnostic performance and value of the new
echnique in various clinical situations and even more time to
stablish its cost-effectiveness. Although we are still enthusias-
ic about the potential of coronary CT, we are also aware of the
act that more scientific evidence should become available
efore we can recommend widespread use of this exciting new
iagnostic modality.
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eply
he letter by Drs. Min and Berman proposes that, pending clinical
ffectiveness trials, “common sense should dictate clinical use” of
omputed tomography coronary angiography (CTCA). They fur-
her opine that “with its very high negative predictive value, an
mmediate benefit of the use of this test would be to eliminate the
eed for unnecessary invasive coronary angiography.” In medicine,
common sense” has often been used to justify approaches to
reatment that ultimately did not withstand careful scrutiny.
ommon sense suggested that use of antiarrhythmic agents to
uppress premature ventricular contractions would benefit patients,
hen in fact such therapies produced the opposite result. “Com-
on sense” is not a suitable alternative to rigorous clinical testing.
n a second letter, Dr. Nicol and colleagues also emphasize a
negative predictive value in excess of 90%,” which they state is
nusual in medicine. These authors provide an explanation for the
oor performance of CTCA in the Meijboom et al. (1) study,
hich they attribute to cut points used to define a “significant”
tenosis.
In response, it must be noted that nuclear scintigraphy also has
ery high negative predictive value, exceeding 90% in multiple
igh-quality studies, accompanied by a more favorable positive
redictive value. Both letters seem to miss the principal issues
aised by the editorial (2). First, the high false-positive rate
ssociated with CTCA represents a potential hazard to patients by
timulating unnecessary invasive angiography. The costs associated
ith false-positive studies are substantial, both in economic terms
nd through potential catheterization-related adverse outcomes,
ncluding morbidity from unnecessary interventions driven by the
oculostenotic reflex.” Both sets of writers fail to acknowledge the
ubstantial radiation burden imposed by CTCA and the potential
o induce fatal malignancies, particularly in younger patients.
Even more importantly, the authors of both letters ignore the
ey premise underlying the editorial (2)—that it is not very useful
o merely identify the presence or absence of stenoses. What
linicians need most is reliable information on the extent of
nducible ischemia, data not provided by angiography. CTCA
annot replace current functional testing methods, because CTCA
